Former Hunton & Williams partner Robert Schulman is facing criminal charges that he tipped off his investment adviser about a pending pharmaceutical merger involving his client.
Schulman, now a partner at Arent Fox, was indicted Wednesday for allegedly telling financial adviser Tibor Klein in 2010 about a planned acquisition by Pfizer of his client, King Pharmaceuticals.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
